Clorox (CLX)
(Delayed Data from NYSE)
$161.57 USD
+0.20 (0.12%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $161.52 -0.05 (-0.03%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$161.57 USD
+0.20 (0.12%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $161.52 -0.05 (-0.03%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth B Momentum B VGM
Zacks News
Clorox (CLX) Q2 Earnings & Revenues Beat Estimates, Rise Y/Y
by Zacks Equity Research
Clorox (CLX) posts solid second-quarter fiscal 2024 results, backed by higher volumes, and gains from pricing actions and cost-saving initiatives.
Clorox (CLX) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Clorox (CLX) delivered earnings and revenue surprises of 100% and 12.01%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
How to Boost Your Portfolio with Top Consumer Staples Stocks Set to Beat Earnings
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Church & Dwight (CHD) Gears up for Q4 Earnings: What to Note?
by Zacks Equity Research
Church & Dwight (CHD) is likely to have seen growth in Q4 earnings, supported by strategic initiatives and consumer demand despite the potential impacts of increased expenses.
Countdown to Clorox (CLX) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
by Zacks Equity Research
Evaluate the expected performance of Clorox (CLX) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Clorox (CLX) Advances While Market Declines: Some Information for Investors
by Zacks Equity Research
In the latest trading session, Clorox (CLX) closed at $144.68, marking a +0.37% move from the previous day.
Church & Dwight (CHD) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Church & Dwight (CHD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's How Clorox (CLX) is Placed Just Ahead of Q2 Earnings
by Zacks Equity Research
Clorox's (CLX) Q2 results are expected to reflect gains from solid demand, cost-saving efforts, strong execution and pricing actions. Its IGNITE strategy and digital investments bode well.
Clorox (CLX) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Clorox (CLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Procter & Gamble (PG) Q2 Earnings Top Estimates
by Zacks Equity Research
P&G (PG) delivered earnings and revenue surprises of 8.24% and 0.49%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Solid Brand Portfolio to Aid Procter & Gamble's (PG) Q2 Earnings
by Zacks Equity Research
Procter & Gamble's (PG) Q2 results are expected to reflect the benefits of a robust brand portfolio, cost-saving and productivity measures, and effective business strategies, offset by elevated costs.
4 Stocks Set to Grow in the Thriving Soap & Cleaning Materials Industry
by Rajani Lohia
The soap and cleaning materials industry looks poised for growth on favorable demand trends, pricing efforts, innovation, digital transformation and brand building amid elevated costs. Players like PG, CL, CHD and CLX look well-poised.
Clorox (CLX) Stock Drops Despite Market Gains: Important Facts to Note
by Zacks Equity Research
In the closing of the recent trading day, Clorox (CLX) stood at $143.35, denoting a -0.57% change from the preceding trading day.
Procter & Gamble (PG) Strong Brands Aid Growth Amid Inflation
by Zacks Equity Research
Procter & Gamble (PG) is navigating market challenges and leveraging growth opportunities in fiscal 2024, showcasing robust sales in key divisions and innovative ventures like Ninjamas.
Is Clorox (CLX) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Here is how Clorox (CLX) and Imperial Tobacco Group PLC (IMBBY) have performed compared to their sector so far this year.
Why the Market Dipped But Clorox (CLX) Gained Today
by Zacks Equity Research
Clorox (CLX) reachead $142.72 at the closing of the latest trading day, reflecting a +0.95% change compared to its last close.
Clorox (CLX) Navigates Challenges, Poised for Sustained Growth
by Zacks Equity Research
Clorox's (CLX) focus on maintaining competitive pricing, sustained innovation, and adherence to a balanced spending approach bodes well amid input-cost inflation and supply-chain woes.
Clorox (CLX) Stock Slides as Market Rises: Facts to Know Before You Trade
by Zacks Equity Research
Clorox (CLX) reachead $141.29 at the closing of the latest trading day, reflecting a -0.81% change compared to its last close.
Constellation Brands (STZ) Beats Q3 Earnings Estimates
by Zacks Equity Research
Constellation Brands (STZ) delivered earnings and revenue surprises of 5.28% and 3.15%, respectively, for the quarter ended November 2023. Do the numbers hold clues to what lies ahead for the stock?
How to Find Strong Consumer Staples Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Clorox (CLX) Rises As Market Takes a Dip: Key Facts
by Zacks Equity Research
Clorox (CLX) closed at $142.59 in the latest trading session, marking a +0.37% move from the prior day.
Clorox (CLX) Surpasses Market Returns: Some Facts Worth Knowing
by Zacks Equity Research
Clorox (CLX) reachead $141.86 at the closing of the latest trading day, reflecting a +0.5% change compared to its last close.
Clorox (CLX) Ascends But Remains Behind Market: Some Facts to Note
by Zacks Equity Research
Clorox (CLX) closed at $141.16 in the latest trading session, marking a +0.4% move from the prior day.
Clorox's (CLX) Growth Strategies Seem Encouraging: Here's Why
by Zacks Equity Research
Clorox's (CLX) IGNITE strategy bodes well. The company's pricing and cost-saving initiatives are aiding margins and, in turn, profitability.
Why Clorox (CLX) Dipped More Than Broader Market Today
by Zacks Equity Research
In the closing of the recent trading day, Clorox (CLX) stood at $141.91, denoting a -0.19% change from the preceding trading day.